News

Lupin’s Memantine HCL tablets are AB-rated to Namenda tablets, indicated for the treatment of modrate to severe dementia of alzheimer’s type. Vinita Gupta, group president and CEO of

The agreement enables Xbrane Bioscience to distribute and sell the protein expression system for both research and commercial purposes, in addition to utilising the system for their in-house

On January 15, 2010, pursuant to the Hatch-Waxman Act, Watson notified Endo’s partners, Teikoku Seiyaku Co and Teikoku Pharma USA, that its ANDA requesting approval from the FDA

COTI-2 is a molecule that inhibits Akt/PKB (Protein kinase B) phosphorylation which leads to caspase-9 activation in cancer cells resulting in apoptosis or programmed cell death. COTI-2 differs

It will specifically facilitate Eastman’s Ensure product line, by providing additional capacity to meet the growing demand in China. Similar to Eastman’s other cellulose esters, Ensure has approximately

Reportedly, Maik Jornitz has been an active member of the PDA since 1994, holding a number of voluntary functions. He was also member of the task forces that

SafeBridge conducted a 60-element review of AMRI programs, procedures and facilities used for the containment and control of potent APIs. Based on the quantitative results of the Potent

Rezaltas is a combination drug featuring the Daiichi Sankyo-developed olmesartan medoxomil (Olmetec), a high-affinity ARB (angiotensin receptor blocker). It also contains azelnidipine (Calblock), a long-acting CCB (calcium channel

The company said that the warehouse expansion has created a 2,200 square metre cGMP compliant facility with an additional 3,500 pallet spaces, temperature controlled storage at 15 –